INNOVATIVE THERAPIES FOR PATIENTS WORLDWIDE
We are a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland.
We put patients at the centre of everything we do. By working closely with physicians, patients and patients advocacy groups, we address unmet medical needs where few or no therapy options currently exist, through in-licensed partnerships and in-house developments.
CLINICAL TRIALS
CSL Vifor is committed to improving the lives of patients around the world with the development of innovative pharmaceutical products. Our passion, values and ethics will continue to drive our approach to research and development activity as we continue to work closely with experts in all areas of medicine to develop new medicines and optimizing our current products for patients in need. We are dedicated to ensuring that our research and clinical development strategy and results are conducted in a transparent and shared way, and in a collaborative manner with researchers, health authorities and especially patients.
Currently, CSL Vifor clinical research is registered and reported using publicly accessible websites sponsored by the regulatory authorities in the US and Europe. Our trials can be accessed on ClinicalTrials.gov (by clicking on this link you are leaving the internet portal www.cslvifor.uk and the scope of responsibility of CSL Vifor UK Limited. These websites have other terms and conditions of use and are subject to other standards/regulations and legislation) and through the EU Clinical Trials Register (by clicking on this link you are leaving the internet portal www.cslvifor.uk and the scope of responsibility of CSL Vifor UK Limited. These websites have other terms and conditions of use and are subject to other standards/regulations and legislation) the public portal of the EudraCT trials system.
UK-NA-2300045 Date of Preparation: June 2023